{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:39Z","timestamp":1793672979603,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.08.073","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T08:51:38Z","timestamp":1535359898000},"page":"1119-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes"],"prefix":"10.1016","volume":"107","author":[{"given":"Manisha J.","family":"Oza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.08.073_bib0005","series-title":"IDF Framework for Action on Sugar","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.biopha.2018.08.073_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2018.08.073_bib0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"DeFronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.08.073_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective","volume":"92","author":"Zaccardi","year":"2015","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.biopha.2018.08.073_bib0025","first-page":"2476","article-title":"Prevalence of and risk factors for type 2 diabetes mellitus in Hyperlipidemia in China","volume":"22","author":"Chen","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2018.08.073_bib0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4239\/wjd.v5.i6.894","article-title":"Sirtuin as novel players in the pathogenesis of diabetes mellitus","volume":"5","author":"Turkmen","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2018.08.073_bib0035","first-page":"14","article-title":"Phytochemicals and complications in type 2 diabetes- an update","volume":"7","author":"Oza","year":"2016","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0040","series-title":"Diabetes, Diabetic Complications, and Flavonoids, in Fruits, Vegetables, and Herbs","first-page":"77","author":"Kulkarni","year":"2016"},{"key":"10.1016\/j.biopha.2018.08.073_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fphar.2018.00739","article-title":"Formononetin treatment in type 2 diabetic rats reduces insulin resistance and hyperglycemia","volume":"9","author":"Oza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.073_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02532865","article-title":"Hypolipidemic principles of Cicer arietinum: Biochanin-A and formononetin","volume":"11","author":"Siddiqui","year":"1976","journal-title":"Lipids"},{"key":"10.1016\/j.biopha.2018.08.073_bib0055","first-page":"185","article-title":"Serum lipid and lipoprotein fractions in bengal gram and Biochanin A induced alterations in atherosclerosis","volume":"43","author":"Gopalan","year":"1991","journal-title":"Indian Heart J."},{"key":"10.1016\/j.biopha.2018.08.073_bib0060","first-page":"6257","article-title":"Use of a mammalian cell culture benzo (a) pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by Biochanin A, an isoflavone from Trifolium pratense L","volume":"48","author":"Cassady","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0065","first-page":"5815","article-title":"Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract","volume":"53","author":"Yanagihara","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.HYP.31.1.522","article-title":"17\u03b2-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth","volume":"31","author":"Dubey","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2018.08.073_bib0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-1573(199903)13:2<163::AID-PTR405>3.0.CO;2-#","article-title":"Inhibitory effects of isoflavones on lipid peroxidation by reactive oxygen species","volume":"13","author":"Toda","year":"1999","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jn\/136.4.899","article-title":"Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPAR\u03b1, PPAR\u03b3, and adipocyte differentiation in vitro","volume":"136","author":"Shen","year":"2006","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2018.08.073_bib0085","first-page":"274","article-title":"Endothelium-independent vasorelaxation of plant-derived estrogen Biochanin A and its mechanism in rat aortic rings","volume":"22","author":"Wang","year":"2006","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.biopha.2018.08.073_bib0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2006.11.045","article-title":"Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation","volume":"417","author":"H.Q","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.08.073_bib0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00436-008-1193-z","article-title":"Antiparasitic activity of Biochanin A, an isolated isoflavone from fruits of Cassia fistula (Leguminosae)","volume":"104","author":"Sartorelli","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0100","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/molecules21050548","article-title":"Neuroprotective effects of Biochanin A against \u03b2-amyloid-induced neurotoxicity in PC12 cells via a mitochondrial-dependent apoptosis pathway","volume":"21","author":"Tan","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2018.08.073_bib0105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1271\/bbb.120675","article-title":"Biochanin A protects against acute carbon tetrachloride-induced hepatotoxicity in rats","volume":"77","author":"Breikaa","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.biopha.2018.08.073_bib0110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1476-5381.2010.00716.x","article-title":"Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase","volume":"160","author":"Thors","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.073_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2011.11.051","article-title":"Antihyperglycemic effect of Biochanin A, a soy isoflavone, on streptozotocin-diabetic rats","volume":"676","author":"Harini","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.073_bib0120","article-title":"Effect of Biochanin A on serum visfatin level of streptozocin-induced diabetic rats","volume":"16","author":"Azizi","year":"2014","journal-title":"Iranian Red Crescent medical journa."},{"key":"10.1016\/j.biopha.2018.08.073_bib0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaim.2016.08.001","article-title":"Biochanin-A attenuates neuropathic pain in diabetic rats","volume":"7","author":"Chundi","year":"2016","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.biopha.2018.08.073_bib0130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/jpet.107.134882","article-title":"Isoflavones promote mitochondrial biogenesis","volume":"325","author":"Rasbach","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.08.073_bib0135","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/mnfr.201500689","article-title":"Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet\u2010induced obese mice","volume":"60","author":"Park","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.biopha.2016.06.025","article-title":"Bauhinia variegata (Caesalpiniaceae) leaf extract: An effective treatment option in type I and type II diabetes","volume":"83","author":"Kulkarni","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.08.073_bib0150","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1021\/acs.jafc.5b01238","article-title":"Effects of D-pinitol on insulin resistance through the PI3K\/Akt signaling pathway in Type 2 diabetes mellitus rats","volume":"63","author":"Gao","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2018.08.073_bib0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","article-title":"Surrogate markers of insulin resistance: a review","volume":"1","author":"Singh","year":"2010","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2018.08.073_bib0160","first-page":"191","article-title":"The estimation of glycogen with the anthrone reagent","volume":"25","author":"Seifter","year":"1950","journal-title":"Arch. Biochem."},{"key":"10.1016\/j.biopha.2018.08.073_bib0165","doi-asserted-by":"crossref","first-page":"E808","DOI":"10.1152\/ajpendo.00361.2010","article-title":"A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain","volume":"299","author":"Jornayvaz","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2018.08.073_bib0170","first-page":"1","article-title":"The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model","author":"Zhang","year":"2009","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.biopha.2018.08.073_bib0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1358\/mf.2004.26.5.831322","article-title":"Reversal of glucose intolerance by pioglitazone in high-fat diet-fed rats","volume":"26","author":"Srinivasan","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2018.08.073_bib0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/108155890405200630","article-title":"Effects of type 2 diabetes on the regulation of hepatic glucose metabolism","volume":"52","author":"Basu","year":"2004","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.biopha.2018.08.073_bib0185","first-page":"1025","article-title":"Use of glycated hemoglobin in the diagnosis of diabetes mellitus and pre-diabetes and role of fasting plasma glucose, oral glucose tolerance test","volume":"4","author":"Alqahtani","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.biopha.2018.08.073_bib0190","first-page":"73","article-title":"Liver disease and diabetes mellitus","volume":"17","author":"Levinthal","year":"1999","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.biopha.2018.08.073_bib0195","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.2337\/diabetes.53.12.3048","article-title":"Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes","volume":"53","author":"Krssak","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.08.073_bib0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ncpendmet1066","article-title":"Dyslipidemia in type 2 diabetes mellitus","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2018.08.073_bib0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/db11-0555","article-title":"Nutrient sensing, autophagy, and diabetic nephropathy","volume":"61","author":"Kume","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.biopha.2018.08.073_bib0210","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.drudis.2010.07.001","article-title":"Role of Sirtuin 1 in metabolic regulation","volume":"15","author":"Silva","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2018.08.073_bib0215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.18632\/aging.100468","article-title":"The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes","volume":"4","author":"Halperin-Sheinfeld","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.biopha.2018.08.073_bib0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cmet.2007.08.014","article-title":"SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B","volume":"6","author":"Sun","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2018.08.073_bib0225","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832626X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832626X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:10:27Z","timestamp":1766023827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221832626X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"alternative-id":["S075333221832626X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.073","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}